|
|
 Previous Article | Table of Contents | Next Article 
Increased resistance to plasmic degradation of fibrin with highly
crosslinked alpha-polymer chains formed at high factor XIII concentrations
CW Francis and VJ Marder
Department of Medicine, University of Rochester School of Medicine and
Dentistry, NY 14642.
We have previously demonstrated that increasing factor XIII concentrations
above that present in plasma (1 U/mL) results in the formation of very high
molecular weight alpha fate polyacrylamide and agarose gel electrophoresis
(SDS-PAGE). In this report, we have examined the effect of such
crosslinking on plasmic susceptibility of fibrin prepared from purified
fibrinogen and from plasma in the presence of factor XIII concentrations
between 0 and 10 U/mL. The crosslinking achieved with purified fibrinogen
at 1 U/mL factor XIII increased resistance to plasmic degradation by 32% as
measured in a radiolabeled clot lysis system. However, further increases in
plasmic resistance occurred at factor XIII concentrations of 2 and 10 U/mL,
the latter decreasing the lysis rate to 45% of that which occurred in the
absence of factor XIII. To achieve the same rate of clot lysis with fibrin
formed using 10 U/mL rather than 1 U/mL of factor XIII, an increase in
plasmin concentration of up to 4.2-fold was required. Similar results were
obtained using clots prepared from plasma in the presence of factor XIII
concentrations greater than 1 U/mL. Since the alpha 2-plasmin inhibitor
content was the same for fibrin at 1 or 10 U/mL factor XIII, the increasing
plasmic resistance could not be attributed to increased binding of the
inhibitor. We conclude that fibrin prepared in the presence of factor XIII
at concentrations exceeding that in plasma shows increased resistance to
plasmic degradation, which is likely explained by the formation of very
high molecular weight alpha polymer chains.
Volume 71,
Issue 5,
pp. 1361-1365,
05/01/1988
Copyright © 1988 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. F. Standeven, A. M. Carter, P. J. Grant, J. W. Weisel, I. Chernysh, L. Masova, S. T. Lord, and R. A. S. Ariens
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness
Blood,
August 1, 2007;
110(3):
902 - 907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Collet, J. L. Moen, Y. I. Veklich, O. V. Gorkun, S. T. Lord, G. Montalescot, and J. W. Weisel
The {alpha}C domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis
Blood,
December 1, 2005;
106(12):
3824 - 3830.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Collet, H. Shuman, R. E. Ledger, S. Lee, and J. W. Weisel
The elasticity of an individual fibrin fiber in a clot
PNAS,
June 28, 2005;
102(26):
9133 - 9137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gerlach, F. Tolle, A. Raabe, M. Zimmermann, A. Siegemund, and V. Seifert
Increased Risk for Postoperative Hemorrhage After Intracranial Surgery in Patients With Decreased Factor XIII Activity: Implications of a Prospective Study
Stroke,
June 1, 2002;
33(6):
1618 - 1623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhu, P. Carmeliet, and W. P. Fay
Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance
Circulation,
June 15, 1999;
99(23):
3050 - 3055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Reed and A. K. Houng
The Contribution of Activated Factor XIII to Fibrinolytic Resistance in Experimental Pulmonary Embolism
Circulation,
January 19, 1999;
99(2):
299 - 304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C.F. Cote, S. T. Lord, and K. P. Pratt
gamma -Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the gamma Chain of Human Fibrinogen
Blood,
October 1, 1998;
92(7):
2195 - 2212.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. V. Mitkevich, J. R. Shainoff, P. M. DiBello, V. C. Yee, D. C. Teller, G. B. Smejkal, P. D. Bishop, I. S. Kolotushkina, K. Fickenscher, and G. P. Samokhin
Coagulation Factor XIIIa Undergoes a Conformational Change Evoked by Glutamine Substrate. STUDIES ON KINETICS OF INHIBITION AND BINDING OF XIIIa BY A CROSS-REACTING ANTIFIBRINOGEN ANTIBODY
J. Biol. Chem.,
June 5, 1998;
273(23):
14387 - 14391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Meyer, J. J. Badimon, J. H. Chesebro, J. T. Fallon, V. Fuster, and L. Badimon
Dissolution of Mural Thrombus by Specific Thrombin Inhibition With r-Hirudin : Comparison With Heparin and Aspirin
Circulation,
February 24, 1998;
97(7):
681 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Hettasch, K. A. Peoples, and C. S. Greenberg
Analysis of Factor XIII Substrate Specificity Using Recombinant Human Factor XIII and Tissue Transglutaminase Chimeras
J. Biol. Chem.,
October 3, 1997;
272(40):
25149 - 25156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kroniger, W.-B. Schwerk, A. V. Bierbrauer, R. Seitz, and R. Egbring
The Role of Factor XIII and Elastase in Gastrointestinal Complications in Henoch-SchoenleinPurpura
Clinical and Applied Thrombosis/Hemostasis,
October 1, 1997;
3(4):
226 - 233.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Kolev, K. Tenekedjiev, E. Komorowicz, and R. Machovich
Functional Evaluation of the Structural Features of Proteases and Their Substrate in Fibrin Surface Degradation
J. Biol. Chem.,
May 23, 1997;
272(21):
13666 - 13675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Biemond, P. W. Friederich, M. Levi, G. P. Vlasuk, H. R. Buller, and J. W. ten Cate
Comparison of Sustained Antithrombotic Effects of Inhibitors of Thrombin and Factor Xa in Experimental Thrombosis
Circulation,
January 1, 1996;
93(1):
153 - 160.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. I. McRitchie, D. Cummings, and O. D. Rotstein
Delayed Administration of Tissue Plasminogen Activator Reduces Intra-abdominal Abscess Formation
Arch Surg,
December 1, 1989;
124(12):
1406 - 1410.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Ritchie, L. C. Lawrie, P. W. Crombie, M. W. Mosesson, and N. A. Booth
Cross-linking of Plasminogen Activator Inhibitor 2 and alpha 2-Antiplasmin to Fibrin(ogen)
J. Biol. Chem.,
August 4, 2000;
275(32):
24915 - 24920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
